Trial intelligence / Profile preview

Tolvaptan in Acute Heart Failure

NCT01733134Phase 3Withdrawn

Modality
Small Molecules
01

Overview

A Phase 3 trial of tolvaptan in Acute Heart Failure (AHF). Status: withdrawn.

02

Drugs

tolvaptan
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT01733134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01733134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call